Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Neurological Medical Device Development
ID: 75N95025Q00006Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

All Other Professional, Scientific, and Technical Services (541990)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/8fe883e7fd724fbeaa98ae8cc333a2cb/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for consulting services related to neurological medical device development as part of the Blueprint MedTech Initiative. The procurement aims to engage a subject matter expert with extensive experience in medical device research and development, who will provide strategic guidance and oversight as a member of the Blueprint MedTech External Oversight Committee. This initiative is crucial for accelerating the translation of innovative medical devices to address nervous system disorders, ensuring that advanced technologies are accessible to patients. Proposals must be submitted electronically by November 21, 2024, with inquiries directed to Tracy Cain at tracy.cain@nih.gov or by phone at (301) 443-6677.

    Files
    Title
    Posted
    RFQ No. 75N95025Q00006.pdf
    The National Institutes of Health (NIH) is soliciting proposals for consulting services focused on neurological medical device development as part of its Blueprint MedTech Initiative. The initiative aims to accelerate the translation of innovative medical devices to address nervous system disorders. The solicitation, numbered 75N95025Q00006, is for a time and materials contract with a base period of twelve months and two optional twelve-month extensions. The selected consultant must have extensive expertise in device development research, clinical testing, and oversight capabilities. Responsibilities include providing strategic guidance as a member of the Blueprint MedTech External Oversight Committee, evaluating project milestones, and mentoring program participants. The solicitation is intended for small businesses, and the estimated performance will largely be remote, with occasional meetings required at government facilities. Evaluation criteria will prioritize technical capability, past performance, and price, with an emphasis on the contractor's ability to fulfill the outlined requirements effectively. The overarching goal of the Blueprint MedTech initiative is to support innovative projects that facilitate patient access to advanced medical technologies through a structured, expert-driven developmental framework. Proposals must be electronically submitted by November 21, 2024, with all necessary certifications provided.
    Similar Opportunities
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Neurosurgery
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking consulting services for a Subject Matter Expert in Neurosurgery as part of the Blueprint MedTech Initiative. The procurement, identified by RFQ 75N95025Q00007, aims to engage a board-certified neurosurgeon with extensive experience in clinical trials, medical device regulation, and the development of neurological devices to provide technical guidance and strategic oversight for medical device development projects. This initiative is crucial for advancing innovative neurotechnologies, with the goal of achieving one successful clinical study per project and attracting significant external investment within a seven-year timeframe. Interested contractors must submit their proposals by November 21, 2024, and can direct inquiries to Tracy Cain at tracy.cain@nih.gov or by phone at (301) 443-6677.
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research purposes, aimed at advancing the understanding of nervous system disorders. This initiative is critical for enhancing biomedical research by providing well-characterized specimens to researchers, thereby facilitating studies that could lead to improved treatments and interventions. Proposals are due by November 25, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending potentially through multiple option years. Interested vendors should contact Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and genomic data for research on psychiatric disorders, thereby facilitating a deeper understanding of the genetic factors involved in mental health. This initiative is vital for advancing both basic and translational research in the field of mental health, ensuring broad access to valuable resources for researchers. Proposals are due by November 21, 2024, and must be submitted electronically via the NIH's eCPS system; interested parties can contact Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    Clinical Site and Study Monitoring for NIMH Funded Research in Global Settings
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for clinical site and study monitoring services for research funded by the National Institute of Mental Health (NIMH) in global settings. The contract, numbered 75N95025Q00022, aims to support efforts in reducing mental health disparities, particularly in low and middle-income countries, and is expected to span five years, commencing on November 25, 2024. Proposals must demonstrate a thorough technical approach, management capabilities, and past performance, with a focus on compliance with regulatory requirements and Good Clinical Practice. The anticipated budget for the contract is up to $2,000,000, and interested parties must submit their proposals by November 22, 2024, at 9 AM EST. For further inquiries, contact Cassandra Conley at cassandra.conley@nih.gov or Rieka Plugge at rieka.plugge@nih.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Chemistry, Manufacturing, and Controls (CMC) services to support the development of drug products. The primary objective of this procurement is to ensure the provision of high-quality formulated drug products necessary for preclinical and clinical studies, adhering to current Good Manufacturing Practice (cGMP) regulations. This contract is crucial for advancing human therapeutics by facilitating the movement of drug candidates through the preclinical development process until the submission of Investigational New Drug (IND) applications. The Request for Proposals (RFP) is expected to be released on or about December 2, 2024, with contract awards anticipated in the third quarter of FY2025. Interested parties can contact Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million anticipated over the contract period from September 1, 2025, to May 14, 2031. Interested parties should direct inquiries to Samson Shifaraw at samson.shifaraw@nih.gov or Valerie Whipple at valerie.whipple@nih.gov, and submit proposals by the deadline of December 3, 2024.
    Science and Health Communication Consulting Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide Science and Health Communication Consulting Services for the National Institute on Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS) Center for Alzheimer’s and Related Dementias (CARD). The primary objective of this procurement is to enhance internal and external communications through various tasks, including the creation of newsletters, scientific manuscript editing, community building initiatives, and the maintenance of the CARD website. This consulting service is crucial for promoting awareness of CARD’s resources and fostering collaboration in Alzheimer’s and related dementias research. Interested contractors must submit their responses by November 21, 2024, to Kevin Alvarez at kevin.alvarez@nih.gov, detailing their capabilities and business size status in accordance with the NAICS code 541690.
    Democratized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Democratized Engineering of Cells Informed by Dynamic Evidence (DECIDE) Exploration Topic. This initiative aims to enhance access to clinically validated curative cell therapies for pediatric patients with rare genetic diseases by advancing quality assurance mechanisms at Academic Medical Centers. The program focuses on developing innovative solutions for small-batch manufacturing of autologous cell therapies, addressing production variability, regulatory challenges, and market failures in this critical healthcare area. Proposals are due by November 18, 2024, at 12 PM EST, with the final solicitation released on October 22, 2024. Interested parties can reach out to the designated contact via the provided email for further inquiries.
    Sequencing Kits and Accessories for Oxford Nanopore Sequencing Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources to provide sequencing kits and accessories for Oxford Nanopore Sequencing Systems as part of a Sources Sought notice. The primary objective of this procurement is to supply the Center for Alzheimer’s Disease and Related Dementias with essential reagents for neurodegenerative disease research, particularly for long read sequencing aimed at identifying causative genes for conditions like Parkinson’s disease. This initiative is aligned with the Global Parkinson’s Genetics Program (GP2), which aims to genotype over 150,000 volunteers globally to enhance understanding of genetic risk factors. Interested companies must submit their capability statements by November 27, 2024, to Eric McKay at eric.mckay@nih.gov, with the anticipated delivery dates for the supplies spanning from September 30, 2025, to September 30, 2027.
    A--To award Indefinite Delivery Indefinite Quantity (IDIQ) Contract for a Biologic
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to fulfill an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the Biological Testing Facility (BTF), which focuses on the preclinical development of contraceptive products. The objective of this procurement is to support the discovery and optimization of anti-fertility agents, ensuring safety and efficacy evaluations that meet regulatory standards for clinical trials, ultimately aiding in the development of high-quality reproductive health products. Interested small businesses must demonstrate their qualifications, including compliance with Good Laboratory Practice and Good Manufacturing Practice, and provide capability statements by November 21, 2024, with the anticipated contract performance period running from September 3, 2025, to September 2, 2032. For further inquiries, interested parties may contact Adelola O. St John at lk202p@nih.gov or call 301-435-6955.